Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 14.19%10.2B | 10.15%6.39B | 10.91%2.87B | -10.30%12.46B | -9.40%8.93B | 63.98%5.8B | 46.16%2.59B | 96.45%13.89B | 121.39%9.86B | 22.15%3.54B |
| Refunds of taxes and levies | 28.79%81.88M | 44.73%61.59M | -1.24%27.26M | -59.91%84.67M | -62.40%63.57M | 80.21%42.55M | 346.78%27.6M | 141.05%211.18M | 131.46%169.07M | -65.71%23.61M |
| Cash received relating to other operating activities | 31.62%1.17B | 30.59%686.02M | 0.57%294.35M | 25.94%1.27B | -5.98%891.89M | 16.26%525.31M | -12.47%292.69M | 29.37%1B | 55.25%948.6M | 30.36%451.85M |
| Cash inflows from operating activities | 15.85%11.46B | 12.06%7.14B | 9.75%3.19B | -8.58%13.81B | -9.92%9.89B | 58.71%6.37B | 37.76%2.91B | 90.37%15.11B | 113.67%10.98B | 21.18%4.01B |
| Goods services cash paid | 17.18%6.34B | 6.89%4.02B | -3.06%1.81B | -20.81%7.34B | -19.45%5.41B | 64.61%3.76B | 35.15%1.87B | 110.86%9.26B | 129.18%6.72B | 32.77%2.29B |
| Staff behalf paid | 6.54%1.84B | 8.61%1.33B | 7.76%801.18M | -2.90%2.54B | -2.04%1.73B | 42.02%1.22B | 47.87%743.52M | 68.90%2.62B | 55.98%1.77B | 7.89%861.25M |
| All taxes paid | 10.42%613.43M | -6.41%364.49M | -24.27%161.75M | -11.36%720.16M | -20.26%555.56M | 17.98%389.46M | 57.92%213.59M | 65.67%812.41M | 82.16%696.75M | 43.72%330.11M |
| Cash paid relating to other operating activities | 3.17%1.87B | 26.60%1.16B | 30.13%557.78M | 83.36%2.47B | 90.60%1.81B | 257.16%914.86M | 205.75%428.64M | 166.14%1.35B | 79.30%950.84M | -8.73%256.15M |
| Cash outflows from operating activities | 12.18%10.67B | 9.27%6.87B | 2.38%3.33B | -6.92%13.07B | -6.14%9.51B | 68.49%6.29B | 50.59%3.26B | 102.32%14.04B | 103.59%10.13B | 23.21%3.73B |
| Net cash flows from operating activities | 107.71%790.76M | 234.01%264.65M | 59.60%-139.79M | -30.53%738.23M | -55.08%380.7M | -71.70%79.23M | -595.71%-346.04M | 6.92%1.06B | 423.46%847.48M | -0.62%280.02M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | --1.92M | --139.57K | --139.57K | -80.76%786.76K | ---- | ---- | ---- | --4.09M | --20.09M | ---- |
| Cash received from returns on investments | 11.37%52.49M | 9.14%11.49M | -25.78%5.02M | -13.88%111.59M | -35.35%47.13M | 20,962.62%10.53M | --6.76M | 1,990.61%129.58M | 145,713.90%72.91M | 0.00%50K |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 1.69%18.93M | -91.70%960.69K | -79.30%517.84K | -89.79%21.89M | -91.02%18.62M | -88.88%11.58M | 149.80%2.5M | 6,988.30%214.46M | 103,811.60%207.36M | 54,580.05%104.08M |
| Net cash received from disposal of subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 3,160.26%674.64M | 3,133.93%669.19M | ---- |
| Cash received relating to other investing activities | -15.33%35.65M | -88.56%4.5M | -88.53%408.36K | -46.99%41.61M | -25.23%42.11M | 3,318.25%39.31M | 84.91%3.56M | 13.39%78.49M | 105.12%56.32M | -81.30%1.15M |
| Cash inflows from investing activities | 1.05%108.99M | -72.17%17.09M | -52.57%6.08M | -84.03%175.88M | -89.49%107.86M | -41.66%61.42M | 337.94%12.82M | 1,010.88%1.1B | 2,019.60%1.03B | 1,547.47%105.28M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -24.93%1.15B | -24.55%766.02M | -22.61%426.14M | 8.01%2.14B | 16.95%1.54B | 143.81%1.02B | 168.80%550.62M | 22.42%1.98B | 43.94%1.31B | -28.13%416.43M |
| Cash paid to acquire investments | 4,809.42%25.71M | 11,928.89%25.71M | --25.71M | -50.13%523.6K | -91.95%523.6K | --213.7K | ---- | --1.05M | --6.51M | ---- |
| Cash paid relating to other investing activities | 201.77%43.77M | 196.72%36.47M | -32.53%5.38M | -91.04%26.91M | -35.41%14.5M | --12.29M | --7.97M | 495.63%300.45M | 49.69%22.45M | ---- |
| Cash outflows from investing activities | -21.18%1.22B | -19.42%828.2M | -18.15%457.22M | -5.07%2.16B | 15.54%1.55B | 146.81%1.03B | 172.69%558.6M | 36.80%2.28B | 44.73%1.34B | -28.13%416.43M |
| Net cash flows from investing activities | 22.84%-1.11B | 16.07%-811.1M | 17.34%-451.14M | -68.68%-1.99B | -356.23%-1.44B | -210.58%-966.36M | -170.30%-545.78M | 24.79%-1.18B | 64.02%-316.26M | 45.70%-311.15M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | 100,124.44%4.51B | 800.00%4.5M | --4.5M | --3M | 12.50%4.5M | -87.50%500K | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | 133.33%10.5M | --4.5M | --4.5M | ---- | 12.50%4.5M | ---- | ---- |
| Cash from borrowing | -43.64%4.2B | -51.61%3.14B | -48.27%2.17B | 45.20%8.07B | 73.31%7.45B | 585.18%6.48B | 1,112.21%4.2B | 209.74%5.56B | 346.62%4.3B | 14.40%946.28M |
| Cash received relating to other financing activities | 525.29%82.03M | ---- | --55.55M | -44.63%385.49M | -47.50%13.12M | -73.59%6.6M | --0 | 1,676.92%696.19M | --24.99M | --24.99M |
| Cash inflows from financing activities | -42.67%4.28B | -51.69%3.14B | -46.98%2.23B | 107.14%12.97B | 72.70%7.47B | 568.70%6.49B | 1,066.87%4.2B | 240.58%6.26B | 347.41%4.32B | 17.42%971.27M |
| Borrowing repayment | -30.40%4.8B | -31.47%4.1B | -41.14%2.18B | 57.86%8.45B | 64.85%6.9B | 579.44%5.98B | 791.53%3.71B | 631.34%5.35B | 573.57%4.19B | 59.78%880.17M |
| Dividend interest payment | 6.44%541.61M | 0.09%479.99M | -83.78%22.06M | -27.80%530.93M | -22.70%508.86M | 2,025.07%479.56M | 1,442.24%136.04M | 140.14%735.41M | 125.38%658.28M | 30.62%22.57M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | ---- | 41.07%72.3M | --66.9M | --66.9M | --66.9M | 13,068.47%51.25M | ---- | ---- |
| Cash payments relating to other financing activities | 124.12%169M | 279.07%126.16M | 188.98%36.44M | -34.60%288.29M | -75.94%75.41M | 1,203.02%33.28M | 404.09%12.61M | 395.81%440.81M | 6,143.21%313.39M | -23.99%2.55M |
| Cash outflows from financing activities | -26.34%5.51B | -27.55%4.7B | -41.89%2.24B | 41.96%9.27B | 45.12%7.48B | 617.24%6.49B | 802.69%3.86B | 479.25%6.53B | 461.49%5.16B | 58.40%905.29M |
| Net cash flows from financing activities | -6,341.49%-1.23B | -89,244.69%-1.57B | -104.46%-15.24M | 1,489.40%3.7B | 97.71%-19.15M | -97.34%1.76M | 606.32%341.75M | -137.46%-266.46M | -1,850.09%-834.53M | -74.19%65.98M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -40.60%4.37M | -27.88%4.78M | 482.14%3.18M | 102.55%10.19M | 68.52%7.35M | 153.93%6.63M | 552.30%545.69K | -43.82%5.03M | -37.08%4.36M | -49.09%2.61M |
| Net increase in cash and cash equivalents | -44.49%-1.55B | -139.94%-2.11B | -9.73%-603M | 751.10%2.46B | -259.25%-1.07B | -2,446.00%-878.74M | -72.12%-549.52M | -358.44%-378.06M | 54.87%-298.95M | 222.81%37.46M |
| Add:Begin period cash and cash equivalents | 87.95%5.28B | 87.63%5.27B | 87.63%5.27B | -11.86%2.81B | -4.11%2.81B | 8.17%2.81B | 8.17%2.81B | 30.05%3.19B | 19.54%2.93B | 5.97%2.6B |
| End period cash equivalent | 114.85%3.73B | 63.81%3.16B | 106.57%4.67B | 87.63%5.27B | -34.04%1.74B | -26.73%1.93B | -0.80%2.26B | 8.17%2.81B | 47.10%2.63B | 8.85%2.63B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- | -- | Tianzhi International Accounting Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.